MeSH term
Frequency | Condition_Probility | Humans | 21 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Female | 7 | 0.0 |
Male | 4 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Base Sequence | 4 | 0.0 |
Cell Line | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
*Intercellular Signaling Peptides and Proteins | 12 | 2.0 |
Molecular Sequence Data | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
DNA Primers | 3 | 0.0 |
Ligands | 4 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
*Signal Transduction | 3 | 0.0 |
Tumor Cells, Cultured | 8 | 0.0 |
Adult | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Animals | 12 | 0.0 |
Receptor, Epidermal Growth Factor/metabolism | 3 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Mice | 7 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
3T3 Cells | 3 | 0.0 |
Comparative Study | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Intercellular Signaling Peptides and Proteins/metabolism/*pharmacology | 2 | 50.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Receptor, Epidermal Growth Factor/genetics/*metabolism | 2 | 1.0 |
Signal Transduction/*drug effects/physiology | 2 | 3.0 |
Tyrosine/metabolism | 2 | 0.0 |
Cell Division/drug effects | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Receptor, Epidermal Growth Factor/*metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Growth Substances/*metabolism | 2 | 1.0 |
Kinetics | 2 | 0.0 |
Neuregulins | 2 | 3.0 |
Rats | 3 | 0.0 |
Growth Substances/*pharmacology | 2 | 0.0 |
